Stockscreener 앱 받기
13.04
1.25%
0.1933
전일 마감가:
$12.85
열려 있는:
$12.93
하루 거래량:
112.21K
Relative Volume:
0.14
시가총액:
$965.88M
수익:
$125.58M
순이익/손실:
$-92.14M
주가수익비율:
-10.50
EPS:
-1.2424
순현금흐름:
$-138.27M
1주 성능:
+11.97%
1개월 성능:
+4.59%
6개월 성능:
-7.06%
1년 성능:
+53.79%
1일 변동 폭
$12.72
$13.10
1주일 범위
$11.60
$13.82
52주 변동 폭
$6.92
$18.69
Xencor Inc Stock (XNCR) Company Profile
명칭
Xencor Inc
전화
626-305-5900
주소
465 N. HALSTEAD ST., PASADENA, CA
Compare XNCR vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XNCR
Xencor Inc
|
13.03 | 952.54M | 125.58M | -92.14M | -138.27M | -1.2424 |
VRTX
Vertex Pharmaceuticals Inc
|
426.56 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
723.20 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
809.65 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.70 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.77 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Xencor Inc Stock (XNCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-24 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-11-24 | 개시 | Truist | Buy |
| 2025-10-29 | 업그레이드 | Barclays | Underweight → Overweight |
| 2025-09-17 | 재개 | Barclays | Underweight |
| 2025-09-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-04-21 | 개시 | William Blair | Outperform |
| 2024-12-12 | 개시 | Wells Fargo | Overweight |
| 2024-12-02 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-04-16 | 재확인 | BTIG Research | Buy |
| 2024-02-28 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-19 | 개시 | BofA Securities | Buy |
| 2022-12-06 | 개시 | Cowen | Outperform |
| 2022-10-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2022-09-21 | 개시 | JP Morgan | Overweight |
| 2022-07-06 | 재개 | Canaccord Genuity | Buy |
| 2022-02-11 | 개시 | BMO Capital Markets | Outperform |
| 2022-01-21 | 개시 | SMBC Nikko | Outperform |
| 2021-12-15 | 개시 | H.C. Wainwright | Buy |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-02-24 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-04 | 개시 | Barclays | Underweight |
| 2020-02-25 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-01-30 | 개시 | RBC Capital Mkts | Outperform |
| 2019-11-20 | 재개 | Guggenheim | Neutral |
| 2019-08-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2019-08-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-06-13 | 개시 | Mizuho | Buy |
| 2019-04-12 | 개시 | Guggenheim | Buy |
| 2019-03-27 | 개시 | Berenberg | Buy |
| 2019-03-15 | 개시 | Raymond James | Outperform |
| 2018-09-10 | 재개 | BTIG Research | Buy |
| 2018-03-28 | 재개 | Leerink Partners | Outperform |
| 2017-03-02 | 개시 | Instinet | Neutral |
| 2017-03-02 | 재확인 | Wedbush | Outperform |
| 2016-10-04 | 개시 | Piper Jaffray | Overweight |
| 2015-12-22 | 개시 | Canaccord Genuity | Buy |
| 2015-08-05 | 재확인 | MLV & Co | Buy |
| 2015-02-12 | 재확인 | Oppenheimer | Outperform |
| 2015-01-28 | 재확인 | MLV & Co | Buy |
| 2014-07-11 | 개시 | Oppenheimer | Outperform |
모두보기
Xencor Inc 주식(XNCR)의 최신 뉴스
Xencor Highlights XmAb942 Phase 1 Data, Previews TL1A/IL-23 Bispecific XmAb412 at DDW 2026 - Yahoo Finance
Buy Rating on Xencor as TL1A Franchise Data and Upcoming Phase IIb Catalyst Support Upside Potential - TipRanks
Xencor, Inc. (XNCR) Discusses Phase I Results for XmAb942 and Preclinical Data for XmAb412Slideshow - Seeking Alpha
Behavioral Patterns of XNCR and Institutional Flows - Stock Traders Daily
Xencor Highlights TL1A Autoimmune Portfolio and IBD Strategy - TipRanks
Xencor presents Phase 1 XmAb942 final results; XmAb412 FIH study on track for 3Q26 - TradingView
Xencor (XNCR) expands TL1A franchise with XmAb942 data and XmAb412 moving to clinic - Stock Titan
MSN Money - MSN
Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW - BioSpace
Xencor (XNCR) Projected to Post Earnings on Wednesday - MarketBeat
Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Xencor (NASDAQ:XNCR) Stock Price Down 8%Should You Sell? - MarketBeat
Xencor Adopts Executive Severance Policy to Support Retention - The Globe and Mail
Xencor Gears Up For DDW 2026 Readouts, 2H26 Pipeline Catalysts - RTTNews
Xencor (NASDAQ:XNCR) Stock Passes Above 50 Day Moving AverageTime to Sell? - MarketBeat
Xencor (NASDAQ: XNCR) seeks approval for 4M new equity plan shares and auditor - Stock Titan
[ARS] Xencor Inc SEC Filing - Stock Titan
Executive severance plan at Xencor (NASDAQ: XNCR) adds change-in-control terms - Stock Titan
(XNCR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
XNCR (Xencor Inc.) reports far narrower Q4 2025 loss than expected alongside 13.7% year over year revenue growth.Financial Data - UBND thành phố Hải Phòng
Is Xencor (XNCR) stock trending sideways or preparing to move (-0.31%) 2026-04-20Stock Idea Sharing Hub - Cổng thông tin điện tử tỉnh Lào Cai
Xencor (NASDAQ:XNCR) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Xencor (NASDAQ:XNCR) Shares Pass Above Fifty Day Moving AverageTime to Sell? - MarketBeat
Ideas Watch: Is Xencor Inc impacted by rising rates2026 Earnings Surprises & Weekly Top Stock Performers List - baoquankhu1.vn
Xencor CFO Cornelissen sells $42990 in stock - Investing.com
Xencor CFO Cornelissen sells $42990 in stock By Investing.com - Investing.com India
Xencor (XNCR) CFO sells 3,499 shares to cover tax on vested RSUs - Stock Titan
Short Covering: What is the target price for Xencor Inc stockPortfolio Value Report & Short-Term High Return Ideas - baoquankhu1.vn
How (XNCR) Movements Inform Risk Allocation Models - Stock Traders Daily
Gap Down: Will Xencor Inc stock hit new highs in YEAR2026 Price Momentum & Trade Opportunity Analysis - baoquankhu1.vn
Aug Closing: Can Xencor Inc expand its profit marginsMarket Weekly Review & Stepwise Trade Execution Plans - baoquankhu1.vn
Portfolio Recap: Is Xencor Inc stock showing strong momentumAnalyst Upgrade & Entry Point Confirmation Alerts - baoquankhu1.vn
Quarterly Recap: Is Xencor Inc stock showing strong momentumWeekly Market Report & Safe Entry Momentum Stock Tips - baoquankhu1.vn
[144] Xencor Inc SEC Filing - Stock Titan
Portfolio Shifts: Should value investors consider Xencor Inc2026 Price Targets & Weekly Return Optimization Alerts - baoquankhu1.vn
Xencor, Inc. (XNCR) Stock forecasts - Yahoo Finance UK
Aug Update: What is the long term forecast for Xencor Inc stock2026 Top Gainers & Community Shared Stock Ideas - baoquankhu1.vn
Xencor, Inc. (XNCR) Stock Forecasts - Yahoo Finance
Is Xencor (XNCR) Stock a Safe Investment | Price at $12.27, Down 0.32%Trending Social Stocks - UBND thành phố Hải Phòng
Fed Meeting: Is Xencor Inc a top pick in the sector2026 Opening Moves & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Gainers Report: Is Xencor Inc stock showing strong momentumStock Surge & Safe Capital Growth Trade Ideas - baoquankhu1.vn
Buy Signal: Can Xencor Inc expand its profit marginsPortfolio Value Summary & Short-Term Trading Alerts - baoquankhu1.vn
Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Xencor sr. VP Desjarlais sells $31,676 in stock - Investing.com
Trading Systems Reacting to (XNCR) Volatility - Stock Traders Daily
Dahiyat, Xencor CEO, sells $80k in XNCR stock - Investing.com
Xencor SVP Eckert sells $17,747 in shares - Investing.com
Xencor (NASDAQ:XNCR) Shares Cross Below 200-Day Moving AverageWhat's Next? - MarketBeat
Aug Weekly: Can Xencor Inc expand its profit marginsRate Hike & Daily Profit Focused Screening - baoquankhu1.vn
Xencor falls as royalty dispute with Astra leads to guidance cut - MSN
RA Capital, insiders report shared 6.5% stake in Xencor (NASDAQ: XNCR) - Stock Titan
Xencor Inc (XNCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.78%
3.01%
자본화:
|
볼륨(24시간):